Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Validation of Sterilization Processes in Injectables

Posted on By

SOP for Validation of Sterilization Processes in Injectables

Standard Operating Procedure for Validating Sterilization Processes in Injectables

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a comprehensive approach for validating sterilization processes used in the manufacturing of injectable pharmaceutical products. This SOP ensures that the sterilization process consistently produces sterile products by meeting the required sterility assurance level (SAL) and ensuring the inactivation of all viable microorganisms. Validation of key parameters such as sterilization temperature, pressure, time, and equipment functionality ensures compliance with regulatory requirements and product safety standards.

2) Scope

This SOP applies to the sterilization processes used for injectable products, including both terminal sterilization and aseptic sterilization techniques. It covers all sterilization methods used, such as autoclaving (steam sterilization), dry heat sterilization, and filtration. The SOP is applicable to new injectable products and those undergoing significant process changes. It ensures that critical parameters such as sterilization cycle time, temperature, pressure, and the effectiveness of sterilization methods are validated to guarantee the sterility and quality of the final injectable product. This SOP is intended for use by quality assurance (QA), production teams, and technical personnel involved in injectable manufacturing and sterilization.

3) Responsibilities

Operators: Responsible for carrying out the

sterilization process according to the approved protocol and ensuring that all critical process parameters are followed and documented.
Quality Assurance (QA): Ensures that the sterilization process is validated in compliance with this SOP and meets all regulatory requirements. QA is also responsible for reviewing and approving all validation documentation and reports.
Production Supervisors: Oversee the sterilization process, ensuring it is performed according to the approved protocol and that operators follow all required procedures.
Validation Team: Responsible for developing the sterilization process validation protocol, executing the validation runs, and analyzing the results.
Maintenance Personnel: Ensures that sterilization equipment, such as autoclaves, sterilizers, and filtration systems, is calibrated and maintained during the validation process.

See also  SOP for Validation of Bottle Filling and Capping for Liquids

4) Procedure

The following steps should be followed for the validation of sterilization processes in injectables:

1. Preparation for Validation:
1.1 Review batch records and product specifications to identify critical process parameters (CPPs) for the sterilization process, such as temperature, pressure, sterilization time, and biological indicators.
1.2 Develop a process validation protocol that includes the objectives, scope, equipment, process flow, and personnel involved in the validation process.
1.3 Ensure that all sterilization equipment, such as autoclaves, dry heat sterilizers, and filtration systems, are calibrated, cleaned, and maintained before initiating the validation process.

2. Validation Protocol:
2.1 Protocol Design: The validation protocol should be based on the type of sterilization method being used (e.g., autoclaving, dry heat, filtration) and the specific requirements for the injectable product.
2.2 Defining Acceptance Criteria: Establish acceptance criteria for critical parameters such as sterilization temperature, pressure, time, and the microbial load reduction. Criteria should also include the acceptable sterility assurance level (SAL) for the product.
2.3 Risk Assessment: Conduct a risk assessment to identify critical quality attributes (CQAs) and corresponding critical process parameters (CPPs) for the sterilization process. This helps ensure that all risks to product sterility and quality are identified and controlled.

3. Execution of Validation:
3.1 Cycle Development: Develop the sterilization cycle, specifying temperature, pressure, and duration based on product requirements and sterilization method.
3.2 Biological Indicators: Use biological indicators (BIs) to validate the effectiveness of the sterilization process. These indicators should be placed at critical locations within the load to ensure proper exposure to sterilizing conditions.
3.3 Sterilization Process: Validate the sterilization process by running multiple cycles under the established parameters. Monitor and record all critical process parameters such as temperature, pressure, and time.
3.4 Temperature and Pressure Mapping: Perform mapping of the sterilization chamber to confirm that uniform temperature and pressure conditions are achieved throughout the entire load.
3.5 Post-Sterilization Testing: After the sterilization process, test the product for sterility using appropriate microbiological methods. Check for the presence of any viable microorganisms and confirm that the product is sterile.
3.6 Documentation: Record all data from the sterilization process, including cycle parameters, biological indicator results, temperature and pressure readings, and sterility test results.
3.7 Stability and Integrity Testing: Conduct post-sterilization stability tests on the injectable product to ensure that the sterilization process does not affect its stability or efficacy.

See also  SOP for Validation of Packaging Processes for Solid Dosage Forms

4. Documentation and Reporting:
4.1 Record all data during the validation process, including batch records, equipment logs, process parameters, and test results.
4.2 Ensure that all forms, reports, and certificates are completed and signed by the responsible personnel.
4.3 Perform statistical analysis of the collected data to assess the process consistency and capability. This analysis should confirm that the sterilization process consistently achieves the required sterility assurance level (SAL) and meets all acceptance criteria.
4.4 Prepare a final validation report that summarizes the results of the validation, including any deviations, corrective actions, and conclusions regarding the sterilization process.

5. Revalidation:
5.1 Revalidate the sterilization process if there are significant changes to the formulation, equipment, or critical process parameters.
5.2 Periodically conduct revalidation to ensure continued compliance with regulatory requirements and confirm that the sterilization process consistently produces sterile injectables.

See also  SOP for Qualification of Isolators in Aseptic Areas

5) Abbreviations

  • QA: Quality Assurance
  • CPP: Critical Process Parameter
  • CQA: Critical Quality Attribute
  • SOP: Standard Operating Procedure
  • SAL: Sterility Assurance Level
  • BI: Biological Indicator

6) Documents

  • Process Validation Protocol
  • Batch Production Records
  • Equipment Calibration Logs
  • Process Validation Reports
  • Microbiological Test Results
  • Sterility Assurance Documentation

7) Reference

  • International Council for Harmonisation (ICH) Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Process Validation
  • ISO 9001: Quality Management Systems – Requirements
  • USP United States Pharmacopeia: Sterility Testing Requirements

8) SOP Version

Version 1.0 – Effective Date: DD/MM/YYYY

Annexure

Template 1: Sterilization Cycle Record

Date Time Operator Initials Temperature (°C) Pressure (psi) Cycle Duration (minutes)
DD/MM/YYYY HH:MM Operator Name Temperature in °C Pressure in psi Duration in minutes
           

Template 2: Biological Indicator Results

Batch No. BI Placement Location Test Results Operator Initials
Batch Number Location Pass/Fail Operator Name
       

Template 3: Sterility Test Record

Batch No. Test Date Test Method Result Operator Initials
Batch Number DD/MM/YYYY Test Method Pass/Fail Operator Name
         

Template 4: Equipment Calibration Record

Equipment ID Calibration Date Calibration Method Calibration Results Operator Initials
Equipment Number DD/MM/YYYY Method Results Operator Name
         

Template 5: Statistical Analysis Data

Sample ID Test Type Mean Standard Deviation Result
Sample Number Test Name Mean Value Standard Deviation Pass/Fail
         
Validations and Qualifications Tags:Cleaning Validation in Pharmaceutical Industry, Computer System Validation in Pharma, Computer System Validation in Pharmaceuticals, Define Validation in Pharma, Equipment Qualification in Pharma, Method Validation in Pharma, Performance Qualification in Pharma, Pharma Validation, Pharmaceutical Cleaning Validation, Pharmaceutical Method Validation, Pharmaceutical Process Validation, Pharmaceutical Process Validation SOP, Pharmaceutical Validation Definition, Pharmaceutical Validation Services, Process Validation Definition in Pharma, Process Validation in Pharma, Process Validation in Pharma Industry, Process Validation in Pharmaceutical Industry, Prospective Validation in Pharma, Qualification in Pharma, Software Validation in Pharmaceutical Industry, SOP for Analytical Method Validations, SOP for Cleaning Validations, SOP for Equipment Validations, SOP for Process Validation, SOP for Validations, Types of Validation in Pharma, Types of Validation in Pharmaceutical Industry, Validation in Pharmaceutical Industry, Validation Life Cycle in Pharma

Post navigation

Previous Post: SOP for Validation of Emulsion Preparation Processes
Next Post: SOP for Drug Discovery Processes

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version